Crossmark

Investigation of receptor radionuclide therapy with 177Lu-DOTATATE in patients with GEP-NEN and a high Ki-67 proliferation index

Crossref DOI link: https://doi.org/10.1007/s00259-017-3925-8

Published Online: 2018-02-01

Published Print: 2018-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nicolini, Silvia

Severi, Stefano

Ianniello, Annarita

Sansovini, Maddalena

Ambrosetti, Alice

Bongiovanni, Alberto

Scarpi, Emanuela

Di Mauro, Francesca

Rossi, Alice

Matteucci, Federica

Paganelli, Giovanni
License Information

Text and Data Mining valid from 2018-02-01
More Information

Article History

Received: 5 July 2017

Accepted: 27 December 2017

First Online: 1 February 2018

Compliance with ethical standards

:

: None.

: The protocol was approved by the Ethics Committee of Area Vasta Romagna and by the competent Italian regulatory authorities. The study was performed in accordance with the principles of Good Clinical Practice and the Declaration of Helsinki.

: All patients gave their written informed consent.